Biotin and Wegovy: separating the evidence from the noise

Why hair thinning comes up with Wegovy in the first place

Clinical trial data for semaglutide 2.4mg (published in the STEP 1 trial in the New England Journal of Medicine) focused on weight, cardiometabolic markers and tolerability. Hair loss did not emerge as a primary endpoint. What has been observed in real-world use, and what the NHS's semaglutide medicines page acknowledges among less common side effects, is hair thinning in some patients. The mechanism most likely at play is telogen effluvium: a temporary disruption to the hair growth cycle triggered when the body undergoes significant physiological stress. Losing a substantial proportion of body weight in a short period qualifies as that kind of stress, regardless of how the loss is achieved. It has been documented after bariatric surgery, very-low-calorie diets and, now, GLP-1 therapies, including the Biotech semaglutide formulation that some patients use as part of their weight loss programme. The hair follicle pauses growth, sheds existing hairs a few months later, and typically resumes normal cycling once weight stabilises. Most people who experience it find shedding peaks around three to six months into treatment and then resolves on its own.

This distinction matters for the biotin question. If the mechanism is physiological stress rather than a nutritional deficiency, supplementing a nutrient you are not deficient in is unlikely to change the outcome.

What biotin actually does, and where the evidence runs out

Biotin (vitamin B7) is a water-soluble vitamin involved in fatty acid synthesis, amino acid metabolism and gene regulation. Genuine biotin deficiency does cause hair loss. It also causes brittle nails and skin problems, and is diagnosable with a blood test. True deficiency is uncommon in adults eating varied diets, because biotin is present in eggs, nuts, seeds, meat and many vegetables. People on very restricted calorie intake during GLP-1 treatment might theoretically edge toward insufficiency if their diet narrows significantly, but this is not the same as a deficiency caused by Wegovy itself.

The broader claim (that supplementing biotin above adequate levels reduces hair shedding) lacks robust clinical backing. A frequently cited 2017 review noted that published case reports of biotin improving hair and nail conditions almost universally involved patients with an underlying deficiency or metabolic disorder. For people with normal biotin status, there is no good trial evidence that additional supplementation prevents or shortens telogen effluvium. If you are curious how this compares with probiotic supplementation, which raises different questions about gut effects during semaglutide treatment, our page on probiotics and Wegovy covers that evidence separately.

One practical flag worth knowing: high-dose biotin supplements (typically those marketed at 5,000–10,000 mcg) can interfere with immunoassay-based laboratory tests, including thyroid function panels and cardiac troponin assays. The MHRA and several clinical bodies have flagged this. If you are taking high-dose biotin and your prescriber orders blood tests, mention it, it will not harm you, but it can produce misleading results that prompt unnecessary further investigation.

Protein, diet quality and what genuinely supports hair health on Wegovy

Because telogen effluvium is stress-driven rather than deficiency-driven, the interventions with the clearest rationale are those that reduce the physiological burden of rapid weight loss. Adequate protein intake is the most frequently emphasised by prescribers. Semaglutide reduces appetite substantially, and without some attention to diet quality, total protein intake can fall below what hair follicles need to sustain normal cycling. Current guidance typically suggests aiming for 1.2–1.6g of protein per kilogram of body weight daily during active weight loss, though personal targets depend on your full picture, your prescriber or a registered dietitian is the right person to advise on yours specifically.

Iron status is also worth checking, particularly in premenopausal women, because iron deficiency is both common and an independent driver of hair shedding that can compound telogen effluvium. A simple blood panel at your GP surgery covers this. Zinc, selenium and vitamin D deficiencies have also been associated with hair loss in some studies, though again the evidence for supplementing above replete levels is weak. A broad-spectrum micronutrient supplement at standard doses is unlikely to cause harm and may address any gaps that narrower appetite creates, but it is a practical backstop rather than a proven hair treatment.

For context on how Wegovy works and what the broader treatment experience looks like, the Wegovy treatment overview on this site covers the mechanism, the dosing schedule and what to expect month by month. If you are further along in your research and thinking about how cost fits in, the Wegovy price guide lays out what private treatment typically costs in the UK right now.

What this means practically if you are on Wegovy or considering it

If hair thinning is your concern, a standard-dose multivitamin or biotin supplement at normal levels (the NHS suggests 35–70 mcg per day for adults, though many supplements contain far more) is low-risk and reasonable. What is not supported by evidence is the idea that a high-dose biotin supplement is a meaningful intervention for telogen effluvium on semaglutide specifically. Spending money on a supplement marketed as a GLP-1 hair fix is, at best, speculative.

The more useful conversation is with your prescriber: about your protein intake, your overall diet quality as appetite decreases, whether a blood panel to check iron and other markers makes sense, and how your treatment is progressing generally. Our prescribers review every patient's situation individually, not as a template. The semaglutide information page covers the wider treatment landscape if you want background before that conversation. Questions about how quickly the treatment produces any effect are also common early on, whether Wegovy works immediately is something we cover in detail separately.

If you are not yet on treatment and are weighing up your options, starting a free consultation with our clinical team is the first step. A GPhC-registered prescriber reviews your answers the same day, no algorithm, no automated gate.